Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow up - Assessment of HydroxyColl Bone Graft Substitute in High Tibial Osteotomy Wedge Grafting.

NCT03601130 is registered in ClinicalTrials.gov with SurgaColl Technologies Limited as lead sponsor.

NCT NCT03601130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03601130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow up - Assessment of HydroxyColl Bone Graft Substitute in High Tibial Osteotomy Wedge Grafting.
Lead sponsor
SurgaColl Technologies Limited
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2018
Completion date
April 29, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee